Table 3.
Details of the vaccine program adopted during the experiment.
| Vaccine | Disease | Type | Concentration | Method | Time |
|---|---|---|---|---|---|
| Nobilis Ma5 + Clone 30 | Infectious bronchitis (IB) and Newcastle disease (ND) | Live vaccine |
Live I.B. strain Ma5: ≥ 3 log10 EID50 Live ND strain Clone 30: ≥ 6 log10 EID50 |
Spray | Day 1 |
| Egymune H5 | Avian influenza H5N1 | Inactivated reassortant vaccine | 8 log10 EID50/mL | Subcutaneous injection | Day 7 |
| Nobilis GUMBORO D78 | Infectious bursal disease | Live vaccine | ≥ 4 log10 TCID50 | Drinking water | Day 12 |
| Nobilis LaSota strain | Newcastle disease (ND) | Live vaccine | ≥ 6 log10 EID50 | Drinking water | Day 17 |
EID50 Median embryo infectious dose, TCID50 median tissue culture infectious dose.